Not applicableStudy completedNCT03287830What this trial is testingFlu2Text: Text Message Reminders for 2nd Dose of Influenza VaccineWho this might be right forInfluenzaVaccination Columbia University 2,105
Post-approval studies (Phase 4)UnknownNCT05996549What this trial is testingCost-effectiveness of the Influenza VaccinationWho this might be right forInfluenza VaccineCost-EffectivenessVaccination International Centre for Diarrhoeal Disease Research, Bangladesh 2,567
Not applicableActive Not RecruitingNCT04747522What this trial is testingSevere Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)Who this might be right forKidney Transplant InfectionSARS-CoV Infection Oslo University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT02301702What this trial is testingMaternal Tdap Immunization in GuatemalaWho this might be right forPertussisWhooping Cough Emory University 286
Post-approval studies (Phase 4)UnknownNCT05415345What this trial is testingImmunogenicity and Safety of Co-immunization With Cecolin and HecolinWho this might be right forHuman Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection Xiamen Innovax Biotech Co., Ltd 480
Testing effectiveness (Phase 2)Study completedNCT00161772What this trial is testingDose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.Who this might be right forTick-borne Encephalitis Pfizer
Post-approval studies (Phase 4)Study completedNCT00984139What this trial is testingPersistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B VaccinationWho this might be right forHepatitis B GlaxoSmithKline 306
Not applicableStudy completedNCT01146912What this trial is testingTextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child PopulationsWho this might be right forInfluenza Columbia University 30,537
Early research (Phase 1)Study completedNCT00393276What this trial is testingDetermining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsWho this might be right forHIV InfectionsHepatitis C National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT00439335What this trial is testingHigher Dose Intradermal H5 VaccineWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 227
Not applicableStudy completedNCT03578120What this trial is testingImmunising Mums Against Pertussis 3Who this might be right forWhooping CoughMaternal Vaccine ExposureImmunization; Infection St George's, University of London 64
Not applicableStudy completedNCT01343485What this trial is testingInnovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine SeriesWho this might be right forGARDASIL Vaccination Planned Parenthood Federation of America 365
Not applicableUnknownNCT05587725What this trial is testingHuman Papillomavirus in Young People Epidemiological Research 3Who this might be right forHuman Papillomavirus InfectionHPVHPV Infection+4 more Monash University 200
Testing effectiveness (Phase 2)WithdrawnNCT05465902What this trial is testingSafety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a BoosterWho this might be right forCOVID-19SARS-CoV-2 Infection WestVac Biopharma Co., Ltd.
Not applicableUnknownNCT05888649What this trial is testingCommunity Preparedness for Outbreak Response and Readiness for Ebola Vaccination in LiberiaWho this might be right forEbola Virus Disease UL-PIRE Africa Center 1,500
Large-scale testing (Phase 3)Study completedNCT02735915What this trial is testingStudy to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and OlderWho this might be right forHerpes Zoster GlaxoSmithKline 70
Not applicableStudy completedNCT04678271What this trial is testingAssessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine UptakeWho this might be right forInfluenzaWhooping Cough Yale University 202
Early research (Phase 1)Study completedNCT00001043What this trial is testingA Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesWho this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT04347395What this trial is testingRespiratory Infection in Older PatientsWho this might be right forPneumoniaRespiratory InfectionDysphagia Changi General Hospital 123
Post-approval studies (Phase 4)Study completedNCT04551677What this trial is testingAnnual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 90